Clinical trial · Observational
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
NCT01692951CI-TRIAL-00028190completedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biomarkers | — | UNRESOLVED | — |
| Fatty Acids | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| serum sample | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Lung adenocarcinoma patients
- description
- Serum samples were collected from patients with lung cancer at the time of their diagnosis, prior to the initiation of treatment. Diagnosis of lung adenocarcinoma was based on pathologic analysis.
- interventionNames
- Other: serum sample
- label
- Control matched to adenocarcinoma
- description
- Control subjects without known cancer and aged from 40 to 75 years should meet at least one of the following criteria: (1) current or ex-smoker with at least a 10 pack-year history, (2) a first-degree relative with a history of lung cancer, or (3) a clinical diagnosis of COPD.
- interventionNames
- Other: serum sample
- label
- Lung squamous cell carcinoma patients
- description
- Serum samples were collected from patients with lung cancer at the time of their diagnosis, prior to the initiation of treatment. Diagnosis of lung squamous cell carcinoma was based on pathologic analysis.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Age from 40 to 80 * Lung adenocarcinoma with pathological diagnosis * Lung squamous cell carcinoma with pathological diagnosis * Control patients should have at least one of the following criteria: (1) current or ex-smoker with at least a 10 pack-year history, (2) a first-degree relative with a history of lung cancer, or (3) a clinical diagnosis of COPD. Exclusion Criteria: \- Lung cancer patient without serum sample before the initiation of treatment
References
Publications (0)
Data not yet available
No reference posted for this study.